Meet Shiao-Pei Weathers, M.D.
Shiao-Pei Weathers, M.D.
Department of Neuro-Oncology, Division of Cancer Medicine
About Dr. Weathers
Dr. Shiao-Pei Weathers is an Associate Professor in the Department of Neuro-Oncology who specializes in primary brain tumors, specifically gliomas. She obtained her medical degree from Wright State University Boonshoft School of Medicine. She then went on to complete an internship at St. Joseph Hospital, neurology residency at the University of Michigan, and a clinical fellowship in neuro-oncology at MD Anderson Cancer Center. Dr. Weathers joined the MD Anderson neuro-oncology faculty in 2015. She has served as PI or co-investigator on numerous clinical trials for patients with newly diagnosed glioblastoma or recurrent glioblastoma, and is actively involved in devising new treatment strategies and combinations for these patient groups. Dr. Weathers also collaborates on research to develop multi-disciplinary treatment approaches for improving the survival and quality-of-life of glioma patients. She serves as Director of the MD Anderson Neuro-Oncology Fellowship Program, Director of the MD Anderson Brain tumor Education and Support Together (BEST) group to educate and counsel primary brain tumor patients and their caregivers.
In the News
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Fellowship Program Director, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Center Medical Director, Division of Brain and Spine Center, The University of Texas MD Anderson Cancer Center, Houston, TX
Section Chief, Brain Tumor Section, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2009 | Wright State University Boonshoft School of Medicine, Dayton, OH, USA, MD, Medicine |
| 2005 | University of Notre Dame, Notre Dame, IN, USA, BA, Psychology |
Postgraduate Training
| 2013-2014 | Clinical Fellowship, Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2012-2013 | Chief Resident, Neurology, University of Michigan, Ann Arbor, MI |
| 2010-2013 | Clinical Residency, Neurology, University of Michigan, Ann Arbor, MI |
| 2009-2010 | Clinical Internship, Internal Medicine, St. Joseph Mercy Hospital, Ann Arbor, MI |
Board Certifications
| 2017 | United Council for Neurologic Subspecialties |
| 2013 | American Board of Psychiatry and Neurology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Administrative Appointments/Responsibilities
Associate Director, Fellowship Program, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2017
Institutional Committee Activities
Member, Brain and Spine Center Patient Experience Committee, 2018 - Present
Member, Graduate Medical Education Committee (GMEC), 2017 - Present
Member, Hematology-Oncology Fellowship Steering Committee, 2017 - Present
Director, MD Anderson BEST (Brain tumor Education and Support Together), 2017 - Present
Member, GME Curriculum Subcommittee, 2015 - Present
Honors & Awards
| 2019 | Finalist, Gerald P. Bodey Award for Excellence in Education, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center |
| 2013 | Golden Beeper Award, University of Michigan |
| 2013 | Neuroscience Day Platform Presentation Winner, University of Michigan |
| 2013 | Status Pedagogicus in Situ Award, University of Michigan |
| 2012 | Making a Difference Award, University of Michigan |
| 2009 | St. Joseph Mercy Preliminary Medicine Intern of the Year, St. Joseph Mercy Hospital |
| 2008 | Gold Humanism Honor Society Wright State Chapter, Wright State University Boonshoft School of Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Aaroe AE, Majd N, Weathers SP, de Groot JF. Potential Neurologic and Oncologic Implications of the Novel Coronavirus. Neuro Oncol 22(7):1050-1051, 2020. e-Pub 2020. PMID: 32296828.
- Trifiletti DM, Malouff TD, McGovern SL, Weathers SP, Wang TJC, Lassman AB, Cahill DP, Shih HA, Brown PD. Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma. Semin Radiat Oncol 30(3):218-222, 2020. PMID: 32503786.
- Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res 26(14):3565-3577, 2020. e-Pub 2020. PMID: 32299815.
- Milbury K, Weathers SP, Durrani S, Li Y, Whisenant M, Li J, Lim B, Weinberg JS, Kesler SR, Cohen L, Bruera E. Online Couple-Based Meditation Intervention for Patients With Primary or Metastatic Brain Tumors and Their Partners: Results of a Pilot Randomized Controlled Trial. J Pain Symptom Manage 59(6):1260-1267, 2020. e-Pub 2020. PMID: 32061834.
- Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino A, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of COVID-19: Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. e-Pub 2020.
- de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol 22(4):539-549, 2020. e-Pub 2019. PMID: 31755915.
- Majd N, Weathers SP, de Groot J. Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases?. Neuro Oncol 21(11):1344-1345, 2019. e-Pub 2019. PMID: 31515554.
- Kesler SR, Harrison RA, Petersen ML, Rao V, Dyson H, Alfaro-Munoz K, Weathers SP, de Groot J. Pre-surgical connectome features predict IDH status in diffuse gliomas. Oncotarget 10(60):6484-6493, 2019. e-Pub 2019. PMID: 31741712.
- Joseph J, Nathenson MJ, Trinh VA, Malik K, Nowell E, Carter K, Weathers SP, Demetri GD, Araujo D, Conley AP. Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor. J Immunother Cancer 7(1):296, 2019. e-Pub 2019. PMID: 31703609.
- Chi AS, Tarapore RS, Hall MD, Shonka N, Gardner S, Umemura Y, Sumrall A, Khatib Z, Mueller S, Kline C, Zaky W, Khatua S, Weathers SP, Odia Y, Niazi TN, Daghistani D, Cherrick I, Korones D, Karajannis MA, Kong XT, Minturn J, Waanders A, Arillaga-Romany I, Batchelor T, Wen PY, Merdinger K, Schalop L, Stogniew M, Allen JE, Oster W, Mehta MP. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol 145(1):97-105, 2019. e-Pub 2019. PMID: 31456142.
- Acquaye AA, Payén SS, Vera E, Williams LA, Gilbert MR, Weathers SP, Armstrong TS. Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews. J Patient Rep Outcomes 3(1):58, 2019. e-Pub 2019. PMID: 31444579.
- Milbury K, Li J, Weathers SP, Mallaiah S, Armstrong T, Li Y, Bruera E, Cohen L. Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers. Neurooncol Pract 6(4):311-320, 2019. e-Pub 2018. PMID: 31386042.
- Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK, Shaw KRM, Meric-Bernstam F, Fuller GN, Chen K, Verhaak RG, Mills GB, Yung WKA, Weathers SP, de Groot JF. Prospective Clinical Sequencing of Adult Glioma. Mol Cancer Ther 18(5):991-1000, 2019. e-Pub 2019. PMID: 30926639.
- Harrison RA, Anderson MD, Cachia D, Kamiya-Matsuoka C, Weathers SS, O'Brien BJ, Penas-Prado M, Yung WKA, Wu J, Yuan Y, de Groot JF. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. Eur J Cancer 112:83-93, 2019. e-Pub 2019. PMID: 30951926.
- Weathers SP, Epner DE. Rookie. J Clin Oncol 37(9):751-753, 2019. e-Pub 2019. PMID: 30742562.
- Hamouda D, Nascimento FA, Weathers SP, Kumar VA. Stroke-like migraine attacks after radiation therapy (SMART) syndrome. Arq Neuropsiquiatr 77(3):215, 2019. PMID: 30970135.
- Milbury K, Li J, Weathers SP, Shih T, Malliaha S, Li Y, Cohen L. A research protocol for a pilot, randomized controlled trial designed to examine the feasibility of a dyadic versus individual yoga program for family caregivers of glioma patients undergoing radiotherapy. Pilot Feasibility Stud 5:95, 2019. e-Pub 2019. PMID: 31367462.
- Milbury K, Mallaiah S, Mahajan A, Armstrong T, Weathers SP, Moss KE, Goktepe N, Spelman A, Cohen L. Yoga Program for High-Grade Glioma Patients Undergoing Radiotherapy and Their Family Caregivers. Integr Cancer Ther 17(2):1534735417689882, 2018. e-Pub 2017. PMID: 28150503.
- Weathers SS, Gilbert MR. Toward Personalized Targeted Therapeutics: An Overview. Neurotherapeutics 14(2):256-264, 2017. e-Pub 2016. PMID: 27995437.
- Srinivasan VM, Ferguson SD, Lee S, Weathers SP, Kerrigan BCP, Heimberger AB. Tumor Vaccines for Malignant Gliomas. Neurotherapeutics 14(2):345-357, 2017. e-Pub 2017. PMID: 28389997.
- Ferguson SD, Xiu J, Weathers SP, Zhou S, Kesari S, Weiss SE, Verhaak RG, Hohl RJ, Barger GR, Reddy SK, Heimberger AB. GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget 7(43):69466-69478, 2016. e-Pub 2016. PMID: 27579614.
- Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol 18(10):1357-66, 2016. e-Pub 2016. PMID: 27370400.
- Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WK, de Groot JF. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol 129(3):487-94, 2016. e-Pub 2016. PMID: 27406589.
- Gatson NT, Weathers SP, de Groot JF. ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma. CNS Oncol 5(1):11-26, 2016. e-Pub 2015. PMID: 26670466.
- Weathers SP, de Groot J. VEGF Manipulation in Glioblastoma. Oncology (Williston Park) 29(10):720-7, 2015. PMID: 26470893.
- Weathers SP, Gilbert MR. Current challenges in designing GBM trials for immunotherapy. J Neurooncol 123(3):331-7, 2015. e-Pub 2015. PMID: 25577401.
- Weathers SP, de Groot J. Resistance to antiangiogenic therapy. Curr Neurol Neurosci Rep 14(5):443, 2014. PMID: 24652451.
- Weathers SP, Kotagal V, Bohnen NI, Chou KL. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease. Parkinsonism Relat Disord 20(1):13-6, 2014. e-Pub 2013. PMID: 24070538.
- Weathers SP, Gilbert MR. Advances in treating glioblastoma. F1000Prime Rep 6:46, 2014. e-Pub 2014. PMID: 24991423.
Abstracts
- Weathers S, Penas-Prado M, Banerjee PP, Bdiwi M, Shaim H, AlsulimanA, Shanley M, Long J, de groot, JF, O’Brien BJ, Majd N, Harrison RA, Kamiya Matsuoka C, Fuller GN, Chi L, Rao G, Lang FF, Shpall EJ, Rezvani K, Hemiberger AB. A Phase I/II Clinical Trial of Autologous CMV-Specific T Cells in Glioblastoma (GBM) Patients to Reveal a Lack of Immune Effector Function. Journal of Clinical Oncology 38((suppl 15)). e-Pub 2020.
- Weathers S, Kamiya Matsuoka C, Harrison RA, Liu DD, Dervin S, Yun C, Loghin ME, Penas-Prado M, Majd N, Yung WK, O’Brian BJ, de Groot JF. Phase I/II Study to Evaluate the Safety and Clinical Efficacy of Atezolizumab (atezo; aPDL1) in Combination with Temozolomide (TMZ) and Radiation in Patients with Newly Diagnosed Glioblastoma (GBM). Journal of Clinical Oncology 38((suppl 15)). e-Pub 2020.
- Milbury K, Weathers SP, Durrani S, Li Y, Carmack C, Buruera E. Acceptability randomized controlled trial a couples-based mind-body intervention for patients with high grade glioma and their partners. Neuro-Oncology 21((suppl 6)):vi205, 2019.
- O’Brien B, Penas-Prado M, Kamiya C, Weathers SP, Yung WK, Loghin M, Harrison RA, Bacha J, Brown D, Johnson G, Langlands J, Schwartz R, Kanekal S, Lopez L, de Groot JF. Phase 2 Study of Dianhydrogalactitol (VAL-083) in Patients with MGMT-unmethylated, Bevacizumab-naïve Glioblastoma in the Recurrent and Adjuvant Setting. Neuro-Oncology 21((suppl 6)):vi14–vi15, 2019.
- Majd N, Mastall M, Hess K, Fuller G, Alfaro-Munoz K, Gule-Monroe M, Huse J, Khatua S, Rao G, Sandbuerg SI, Wefel J, Yeboa D, Zaky W, Mahajan A, Puduvalli V, Suki D, Weathers SP, Harrison R, de Groot J, Penas-Prado M.. Characterization of Adult Medulloblastoma: A Retrospective Review of 200 Patients at MD Anderson Cancer Center. Neuro-Oncology 21((suppl 6)):vi231-vi232, 2019.
- Metrus N, Kamiya C, Weathers SP, Seligman C, O'Brien B.. Improvement of Leptomeningeal Disease Following Infectious Meningitis. Neuro-Oncology 21((suppl 6)):vi59, 2019.
- Sinicrope KD, Barata P, Walker J, Tremont-Lukats IW, Groves M, Loghin M, Seligman C, Ferguson S, Weathers SP, Penas-Prado M, Kamiya-Matsuoka C, Harrison R, Tummala S, Trevino CR, Peinado S, Murthy RK, Seyedeh D, de Groot J, O'Brien B. Intrathecal Topotecan for Leptomeningeal Metastasis in Solid Tumors: The MD Anderson Experience. Neuro-Oncology Advances 1(suppl_1):i8, 2019.
- Trevino CR, Weathers SP, Alfaro-Munoz K, Hallatt G, Williford GL, Park M, Liu DD, Overeen T, Mandel JJ, de Groot JF. Retrospective Review for Outcomes of IDH Mutant, 1p/19q Co-deleted Gliomas Based on Initial Treatment. Journal of Clinical Oncology 37(suppl), 2019.
- Harrison RA, Liu R, Rao V, Petersen M, Dyson H, Weathers SS, Alfaro-Munoz K, de Groot JF, Kesler S.. Evaluating the Capacity of Connectome Analysis to Predict Survival in High-Grade Astrocytoma. Journal of Clinical Oncology 37(suppl_15), 2019.
- Metrus NR, Harrison RA, Ferguson S, Weathers SP. Isolated CNS Blastic Plasmacytoid Dendritic Cell Neoplasm in a Patient with AML. Neurology 92((suppl 15)), 2019. e-Pub 2019.
- Hamouda D, Jazebi N, Weathers SP. Sequelae of Cranial Irradiation: Stroke-like Migraine Attacks After Radiation Therapy (SMART) Syndrome. Neurology 92((suppl 15)), 2019. e-Pub 2019.
- Kamiya Matsuoka C, Metrus N, Weathers S, Ross J, Shaw KR, Penas-prado M, Loghin ME, Alfaro-Munoz K, O'Brien BJ, Harrison R, Sadighi Z, Majd N, Yung WK, Meric-Bernstam F, Hambardzumyan D, de Groot J. Is Immuno-Oncology Therapy Effective in Hypermutator Glioblastomas with Somatic or Germline Mutations?. Annals of Oncology 30((suppl 5)):v143-v158, 2019.
- de Groot J, Penas-Prado M, Mandel J, O’Brien B, Weathers S, Loghin M, Kamiya-Matsuoka C, Zhou S, Colen R, Hunter K, Fuller G, Huse J, Rao G, Weinberg J, Prabhu S, Ferguson S, Yuan Y, Vence L, Allison J, Sharma P, Heimberger A. Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma Patients. Neuro-Oncology 20((suppl 6)):vi2, 2018.
- Penas-Prado M, Weathers S, Zhou S, Kamiya-Matsuoka C, O’Brien B, Loghin M, Harrison R, Pei B, Ictech S, Hunter K, Yung WK, de Groot J, Shpall EJ, Heimberger A, Rezvani K. A Phase I/II Clinical Trial of Autologous CMV-Specific Cytotoxic T Cells (CMV-TC) for Glioblastoma: Dose Escalation and Correlative Results. Neuro-Oncology 20((suppl 6)):vi2–vi3, 2018.
- Mastall M, Majd N, Fuller G, Gule-Monroe M, Huse J, Khatua S, Rao G, Sandberg D, Wefel J, Yeboa D, Zaky W, Mahajan A, Puduvalli V, Suki D, Alfaro K, Weathers S, Harrison R, de Groot J, Penas-Prado M. Characterization of Adult Medulloblastoma Patients at Recurrence: Retrospective Review of the MD Anderson Cancer Center Experience. Neuro-Oncology 20((suppl 6)):vi239, 2018.
- Metrus N, Daher A, Harrison R, Majd N, Maraka S, Nam J, Trevino C, Weathers S, O’Brien B, Kamiya-Matsuoka C, Loghin M, Alfaro K, Hunter K, Yung WK, de Groot J, Penas-Prado M. Analysis of Challenges to Accrual in Clinical Trials for Newly Diagnosed Glioblastoma. Neuro-Oncology 20((suppl 6)):vi141, 2018.
- Barbara O’Brien B, de Groot J, Kamiya-Matsuoka C, Weathers S, Bacha J, Brown D, Steino A, Langlands J, Schwartz R, Kanekal S, Lopez L, Penas-Prado M. Phase 2 Study of Dianhydrogalactitol (VAL-083) in Patients with MGMT-Unmethylated, Bevacizumab-Naïve Recurrent Glioblastoma. Neuro-Oncology 20((suppl 6)):vi17, 2018.
- Weathers S, Kamiya-Matsuoka C, Dervin S, Yun C, Loghin M, O’Brien B, Harrison R, Yung WK, Penas-Prado M, de Groot J. Safety Run-In Results for a Phase I/II Study to Evaluate the Safety and Clinical Efficacy of Atezolizumab (Atezo; aPDL1) in Combination with Temozolomide (TMZ) and Radiation in Patients with Newly Diagnosed Glioblastoma (GBM). Neuro-Oncology 20((suppl 6)):vi9–vi10, 2018.
- Mastall M, Majd N, Fuller G, Gule-Monroe M, Huse J, Khatua S, Rao G, Sandberg D, Wefel J, Yeboa D, Zaky W, Mahajan A, Puduvalli V, Suki D, Alfaro K, Weathers S, Harrison R, de Groot J, Penas-Prado M. Adult Medulloblastoma: Analysis of Use of Chemotherapy in Clinical Practice. Neuro-Oncology 20((suppl 3)):iii325, 2018.
- Kamia Matsuoka C, Metrus NR, Shaw KR, Penas-Prado M, Weathers, SS, Loghin ME, Alfaro-Munoz K, Yuan Y, O'Brien BJ, Harrison, RA, Yung, WK, Meric-Bernstam F, de Groot, JF. The Natural Course of Hypermutator Gliomas. Journal of Clinical Oncology 36(suppl), 2018.
- Penas-Prado M, Rezvani K, Weathers SS, Zhou S, Kamiya Matsuoka C, O'Brien BJ, Loghin ME, Harrison RA, Pei BL, Ictech S, Hunter K, Yung WK, de Groot JF, Shpall EJ, Heimberger AB. A Phase I/II Clinical Trial of Autologous CMV-Specific Cytotoxic T Cells (CMV-TC) for Glioblastoma: Dose Escalation Results. Journal of Clinical Oncology 36(suppl). e-Pub 2018.
- de Groot JF, Penas-Prado M, Mandel JJ, O'Brien BJ, Weathers, SS, Zhou S, Hunter K, Alfaro-Munoz K, Fuller GN, Huse J, Rao G, Weinber JS, Prabu SS, Ferguson SD, Yuan Y, Vence LM, Allison JP, Sharma P, Heimberger AB. Window-of-Opportunity Clinical Trial of a PD-1 Inhibitor in Patients with Recurrent Glioblastoma. Journal of Clinical Oncology 36((suppl 15)), 2018.
- Gatson N, Brimley C, Rao G, Chi L, Prabhu S, Weathers S. Role for Laser Interstitial Thermal Therapy (LITT) to Manage Progressed Glioblastoma During Pregnancy. Neuro-Oncology 19((suppl 6)):vi269, 2017.
- Zheng S, Wei W, Chen K, Alfaro-Munoz K, Eterovic AK, Shaw K, Mills G, Meric-Bernstam F, Verhaak R, Yung WK, Weathers S, de Groot J. Deep Panel Sequencing of a Prospectively Collected Glioma Cohort. Neuro-Oncology 19((suppl 6)):vi98-vi99, 2017.
- Milbury K, Mallaiah S, Mahajan A, Armstrong T, Weathers S, Li J, Cohen L. Feasibility Randomized Controlled Trial of a Dyadic Yoga Program for Patients with Brain Tumors Undergoing Radiotherapy and Their Family Caregivers. Neuro-Oncology 19((suppl 6)):vi205, 2017.
- Milbury K, Lopez G, Weathers S, Eto O, Li J, Cohen L. Illness Communication, Spousal Support and Symptom Burden in Couples Coping With Glioma. Neuro-Oncology 19((suppl 6)):vi203, 2017.
- Kamiya-Matsuoka C, Shaw K, Loghin M, Penas-Prado M, O'Brien B, Weathers S, Alfaro-Munoz K, Yung WK, de Groot J. The Natural Course of Hypermutator Gliomas. Neuro-Oncology 19((suppl 6)):vi179, 2017.
- Abrol S, Kotrotsou A, Hassan A, Elshafeey N, Agarwal A, Hassan I, Idris T, Salek K, Farid N, McDonald C, Weathers SP, Bahrami N, Bergamaschi S, Elakkad A, Alfaro-Munoz K, Moron F, Huse J, Weinberg J, Heimberger A, Sawaya R, Kumar A, de Groot JF, Law M, Zinn P, Colen R. Radiomic Analysis of Pseudo-Progression Compared to True Progression in Glioblastoma Patients: A Large-Scale Multi-Institutional Study. Journal of Clinical Oncology 19(suppl_6):vi162-vi163, 2017.
- Nam J, Harrison RA, Weathers SS, Pillainayagam C, de Groot JF, Kamiya Matsuoka C, Yung WK, Li J, Ferguson SD, O'Brien BJ. Association of Clinical Phenotype and Treatment History with Survival in Adult Brainstem Glioblastoma. Journal of Clinical Oncology 35(15):Suppl, e13539-e13539, 2017.
- Weathers SP, Bolanos EV, Payen S, Acquaye A, Ng A, Weinberg J, Brown P, Armstrong T. Measuring Mobility and Disability in Patients with Gliomas. Neuro Oncol 18((suppl 6)), 2016.
- Armstrong T, Payen S, Vera E, Acquaye A, Alfaro-Munoz K, Nielsen D, Penas-Prado M, Weathers SP, O'Brien B, de Groot J. The Impact of Molecular Diagnostics on Function and Symptom Burden in Glioma Patients. Neuro Oncol 18((suppl 6)), 2016.
- Gatson NN, Pillainayagam C, Rao G, Chi TL, Prabhu S, Weathers SP. Laser Interstitial Thermal Therapy (LITT) to Manage Progressed Glioblastoma During Pregnancy. Neuro Oncol 18((suppl 6)), 2016.
- Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Immune Checkpoint Blockade as a Potential Therapeutic Target: Surveying CNS Malignancies. Neuro Oncol 18(10):1357-66, 2016. e-Pub 2016. PMID: 27370400.
- Weathers SP, Han SX, Liu DD, Conrad CA, Gilbert MR, Loghin BO, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Yung WK, de Groot JF. A Randomized Phase II Trial of Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) in Adults with Recurrent Glioblastoma. Journal of Clinical Oncology(33):(suppl;abstr 2005), 2015.
- Mammoser AG, Weathers SP, Seewald NJ, Taylor JMG, Junck L. Primary CNS Lymphoma; A Review of the University of Michigan Experience 2004-2013. Journal of Clinical Oncology(33):(suppl;abstr e13012), 2015.
Book Chapters
- Ferguson SD, Weathers SP, Heimberger AB. Chapter 34: Immune Checkpoint Blockade in Glioma. In: Oligodendroglioma: Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment. 1st. Elsevier Inc./Academic Press: San Diego, 387-396, 2019.
- Harrison RA, Nam JY, Weathers SP, DeMonte F. Intracranial dural, calvarial, and skull base metastases. In: Handb Clin Neurol, 205-225, 2018.
- Weathers SP, O'Brien BJ, de Groot JF. Chapter 40: Tumors of the Central Nervous System. In: The MD Anderson Manual of Medical Oncology. 3rd. McGraw-Hill Education: New York, 826-856, 2016.
- Weathers SP, O'Brien BJ, de Groot JF, Yung WK. Chapter 18: Targeted Therapy in Solid Tumors: Brain. In: Targeted Therapy in Translational Cancer Research. Wiley-Blackwell, 179-189, 2015.
Patient Reviews
CV information above last modified July 12, 2024